A 42/20 mmHg fall in blood pressure with only a 4-beat/minute pulse rise gives a ΔHR/ΔSBP ratio of about 0.10 beats/min/mmHg. That makes neurogenic orthostatic hypotension a serious possibility. In a person with parkinsonism, the board-level trap is to leap from that autonomic clue to a diagnosis of multiple system atrophy (MSA). The useful question is narrower: what does this measurement contribute to MSA criteria, and what evidence must still be established?
The reading supports an autonomic feature—not a disease label
The systolic pressure falls from 154 to 112 mmHg and the diastolic from 88 to 68 mmHg within three minutes. Both changes exceed usual orthostatic-hypotension thresholds; the systolic fall also exceeds the larger threshold sometimes used when supine blood pressure is elevated. A nearly flat heart-rate response supports impaired autonomic compensation, provided the measurements are reliable and a rate-limiting medication or another confounder is not responsible.
For MSA criteria, the distinction between ordinary orthostatic hypotension and neurogenic orthostatic hypotension matters. The Movement Disorder Society (MDS) criteria operationalize neurogenic orthostatic hypotension with a systolic pressure fall of at least 20 mmHg, usually accompanied by a diastolic fall of at least 10 mmHg, and a ΔHR/ΔSBP ratio below 0.5 beats/min/mmHg. The fall must occur within three minutes for clinically established MSA and within ten minutes for clinically probable MSA. Secondary causes, including diabetic autonomic neuropathy, and medications that impair the heart-rate response should be considered and excluded as applicable. The ratio in this example is about 0.10, but it does not identify the cause of autonomic dysfunction.
That distinction matters because autonomic failure can occur in MSA, Parkinson disease, dementia with Lewy bodies, pure autonomic failure, diabetic autonomic neuropathy, and other peripheral neuropathies. Volume depletion and medication effects can also aggravate a postural pressure fall. A plausible physiologic mechanism is not the same as an etiologic diagnosis.
Know what the finding counts toward
MSA criteria combine clinical domains; they do not diagnose MSA from one dramatic test result. The categories also differ in what additional evidence is required.
| MDS category | What neurogenic orthostatic hypotension contributes | What else is required |
|---|---|---|
| Clinically probable MSA | One core domain: autonomic dysfunction. | At least one additional core domain—parkinsonism or cerebellar syndrome—plus at least one supportive clinical feature (isolated erectile dysfunction does not count) and no exclusion criteria. MRI markers are not required. |
| Clinically established MSA | One core domain: autonomic dysfunction, including qualifying neurogenic orthostatic hypotension within three minutes. | Poorly levodopa-responsive parkinsonism or a cerebellar syndrome; at least two supportive clinical features; at least one characteristic MRI marker; and no exclusion criteria. |
For clinically probable MSA, autonomic dysfunction, parkinsonism, and cerebellar syndrome are the three core domains. The criteria require at least two of them, in any combination. Multiple autonomic symptoms may make autonomic involvement more convincing, but they do not turn one domain into two.
The time course also matters. Neurogenic orthostatic hypotension within three minutes can contribute to the autonomic feature for clinically established MSA; delayed neurogenic orthostatic hypotension within ten minutes can contribute for clinically probable MSA. These are classification criteria, not a reason to label an incomplete vignette. The supplied readings do not establish the patient’s disease duration, levodopa response, cerebellar findings, MRI markers, or exclusion criteria.
Don’t turn vague bladder or sexual symptoms into criteria
A report of “urinary problems” is not automatically a qualifying MSA feature. Clarify whether there is unexplained urinary urge incontinence or voiding difficulty, and whether a postvoid residual has been measured. Consider alternative explanations such as infection, outlet obstruction, or pelvic-floor causes.
Sexual symptoms need the same care. Erectile dysfunction (ED) is not, by itself, a core autonomic feature of MSA. For clinically probable MSA, ED in a man younger than 60 years may count as a supportive feature, but it cannot satisfy the supportive-feature requirement by itself; another supportive clinical feature is needed.
This is where a board answer can be both decisive and appropriately limited: the orthostatic findings raise concern for neurogenic autonomic failure; specific urinary findings may add relevant evidence if present; neither should be converted into a confirmed MSA diagnosis without the rest of the criteria.
Early autonomic failure is a Parkinson disease red flag, not an automatic exclusion
The MDS Parkinson disease criteria treat severe autonomic failure within the first five years of disease as a red flag. The orthostatic component includes a fall of at least 30 mmHg systolic or 15 mmHg diastolic within three minutes, in the absence of dehydration, medication effects, or another plausible cause. The example’s pressure drop exceeds that numeric threshold, but the disease timeline and potential confounders are not supplied. A red flag should prompt reconsideration of the diagnosis and be weighed within the criteria; it is not an absolute exclusion criterion or proof of MSA.
First establish when the autonomic symptoms began relative to the motor syndrome. Then check for contributors that can imitate or worsen neurogenic physiology, including diabetes, volume depletion, and medicines that lower blood pressure or blunt the heart-rate response. If urinary symptoms are reported, define them and consider objective bladder assessment. The neurologic examination, longitudinal motor course, levodopa response, and—when the clinical question warrants it—MRI all help determine how much weight the autonomic finding deserves.
Practical takeaways
- The given pressure fall meets orthostatic-hypotension thresholds; the small pulse rise raises suspicion for a neurogenic contribution, not a specific disorder.
- In MSA criteria, neurogenic orthostatic hypotension contributes to the autonomic domain. It does not replace the additional core, supportive, and—when required—MRI findings.
- Distinguish clinically probable from clinically established MSA; their autonomic timing and evidence requirements differ.
- Characterize urinary and sexual symptoms rather than counting vague reports as criteria.
- Severe early autonomic failure meeting the Parkinson disease red-flag definition should prompt reconsideration, but is not a stand-alone exclusion or proof of MSA.
